VK8-20783-42850
2 vaccinations
3 coded responses
14 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 410 / KY
- Registered
- 2021-01-07
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-07
Registered in v-safe
-
2021-01-07
Dose 1 — Moderna
-
2021-01-07
Survey response — day 0, dose 1MedDRA: Vision blurred — Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessFree text: Vision blurred slightlyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-08
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-01-09
- 2021-01-12
- 2021-01-23
- 2021-01-30
-
2021-02-03
Dose 2 — Moderna
-
2021-02-03
Survey response — day 0, dose 2MedDRA: Skin warm, Vision blurred — Feeling: Good · FeverFree text: Slight blurred vision, skin is warmMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-04
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Fatigue or tiredness · Be unable to workAdult check-in
-
2021-02-05
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling · NoneAdult check-in
- 2021-02-06
- 2021-02-09
- 2021-02-12
- 2021-02-19
-
2022-02-05
Survey response — 12 months, dose 2MedDRA: Basal cell carcinoma, Neuroma — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: I got Morton's Neuroma in foot and Basil Cell cancer on foreheadMedDRA releases: 2024-11 · check-in free text available
-
2022-02-05
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-02-10
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-07 | Moderna | |
| 2 | 2021-02-03 | Moderna |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-02-05 | Successful 2022-02-10 |
Participant prefers to complete VAERS report online |
Free text
Release 1 — day 0, dose 1
Systemic reaction (other): Vision blurred slightly
Release 3 — day 0, dose 2
Systemic reaction (other): Slight blurred vision, skin is warm
Release 11 — 12 months, dose 2
Symptoms: I got Morton's Neuroma in foot and Basil Cell cancer on forehead
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Basal cell carcinoma | · | · | ✓ |
| SD | Neuroma | · | · | ✓ |
| SRO | Skin warm | ✓ | ✓ | ✓ |
| SRO | Vision blurred | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release